Great discernment! I concur!
Your estimate sounds very reasonable.
The model I use for estimating ENZC's 12 Month PPS moving forward is CytoDyn who has developed the Monoclonal Ab "Leronlim" which is a humanized IgG4 mAb that blocks CCR5, a cellular receptor important in HIV infection.
Although it has shown to be effective in various clinical trials in some patients, it is NOT curative, NOT Monotherapy, AND it has a far inferior capacity to treat HIV AND it also requires dual administration 3X/week of Standard of Care (HAART) Drug Therapy that carries multiple potential side effects including organ damage.
Importantly, it has NOT been shown to be effective in multiple HIV sub-types, nor prevent viral escape, and at best in general, it helps lower viral load to a moderate degree, but NOT in all patients.
MY POINT?? Cytodyn's 52 week trading history shows it went from $0.26 cents to $10, but yet it's not even in the same league as Enzc-BioClonetics Clone-3 Ab, NOT even close!
Therefore IMO, I envision Enzc-Bioclonetics to easily climb into the $5-$10 PPS trading range well within the next 12 months from now if not HIGHER, especially with things moving forward like they are, i.e. Merger finalized any day, SEC filings coming current, getting things underway at Texas A&M-Warp Speed Fast Tack initiative, Dr. Moss on board, funding applications with NIH/NSF, forthcoming Primate Studies at U.C. Davis, and likely the soon appearance of a BigPharma partner being named for formal patient trials, and planning for production and global commercialization of their Monotherapy HIV Vaccine that might include Covid-19 when it's all said and done.
All I'm saying is A LOT can happen within the next 12 months based on what we now know, that could easily cause the company's stock to soar, notwithstanding the potential of a Big Pharma BUY OUT!...a very likely possibility!!!
The fundamental reason why??? Disruption Biotechnology!
Please keep in mind that ALL the above is ONLY AN OPINION...NOTHING ELSE, although I believe it is a reasonable "comparative" analogy estimate!
Be well and prosper...
